Drugs / Isorsorbide Dinitrate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02228408 | Aug 2017 → May 2019 | end stage renal failure | Brigham and Women's Hospital | Completed | Mixed |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Isorsorbide Dinitrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02228408 ↗ |